Greetings from New York City! My name is Albert Bourla, and I am Chairman and CEO of Pfizer.
我在纽约向大家问好！我是辉瑞公司董事长兼首席执行官艾伯乐，
As some of you may know, Pfizer has a long history in China. More than thirty years ago, when China opened its doors to foreign investors, we were one of the first multinational pharmaceutical companies on the ground. Since those early days, we have been privileged to witness firsthand China’s remarkable economic transformation.
Today, Pfizer has nearly 7,000 employees in China, including colleagues at two R&D centers in Shanghai and Wuhan. We have introduced more than 60 innovative products that advance public health and extend and improve life for Chinese patients…and invested more than 1.5 billion U.S. Dollars in China to date. We are proud of the active role we have played in China’s health system throughout these many years, and look forward to continuing our work for generations to come.
During this unprecedented time, it is both a great privilege and a huge responsibility to serve patients around the world. The COVID-19 pandemic has taught us many things about the power of science, the importance of resilient healthcare systems, and how interconnected our world really is. It also has taught us that nothing is impossible if we work together.